Clinical Reports
A Case in Which Saibokuto was Effective for Chest Pain and Respiratory Distress Due to the After Effects of COVID-19
2022 Volume 73 Issue 3 Pages 331-334
Details
2022 Volume 73 Issue 3 Pages 331-334
Many patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) complain of respiratory distress, chest pain, and arthralgia even after their recovery. We tried to give saibokuto to a 61-year-old man who has suffered from those symptoms as after effects of COVID-19 for more than 2 months. We report that after administration of saibokuto, almost all symptoms have disappeared within 3 weeks.
